Electrospun biodegradable membrane inserts (POP:7/27/2020 to 04/26/2021)

Ended Definitive Contract Awarded

Contract number
75N95020C00018
Awardee
Awarding agency
Obligated
$225,000

Award facts

Opportunity
Contract value 100% obligated
$225,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
NAICS code
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 6 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Ashland, MA 01721, USA
Research
SBIR Program Phase I Action

Award details come from SAM.gov/FPDS.

About this award

The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a $225,000.00 firm fixed price Small Business Innovation Research (SBIR) Phase I contract to Mattek Corp, a for-profit manufacturer of human tissue models and assay kits. The contract is for the development of electrospun biodegradable membrane inserts, to be performed from July 27, 2020 to April 26, 2021. Mattek previously supported federal biomedical research and testing through SBIR and other contracts with NIH, CDC, EPA, and the Navy, providing respiratory, skin, and intestinal tissue models. This contract aligns with the NIH/CDC SBIR program goals to stimulate innovation, strengthen the role of small businesses, and increase commercialization of federal research and development.

Quick answers

Who was awarded contract 75N95020C00018?

75N95020C00018 was awarded to Mattek Corporation by National Institute on Drug Abuse (National Institutes of Health) on July 27, 2020.

How much is contract 75N95020C00018 worth?

The government has obligated $225,000 on 75N95020C00018.

Which agency awarded contract 75N95020C00018?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95020C00018, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Was contract 75N95020C00018 competed?

The extent of competition for 75N95020C00018 was full and open competition after exclusion of sources. The government received 6 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award